AGILE trial reports on antiviral activity of molnupiravir in vaccinated and unvaccinated individuals infected with contemporaneous variants of SARS-CoV-2
The antiviral drug molnupiravir received regulatory approval for treating people … Continued
Learning and confirming in publicly funded antiviral trials
Reporting the phase 2 results from the UK AGILE CST-2 … Continued
First antiviral pill to treat Covid-19 approved in UK
A “game-changing” antiviral pill that is part of the AGILE … Continued
People across the south to be part of pioneering research in the fight against COVID-19
People across the south are being asked to play their part in helping vital research into new COVID-19 treatments.
A ground-breaking clinical trial platform being led by researchers at the Southampton Clinical Trials Unit is now recruiting patients through the NIHR Southampton Clinical Research Facility within the General Hospital.
Groundbreaking COVID-19 treatments to be fast-tracked through clinical trials
The world’s most innovative treatments for COVID-19 will soon be … Continued
Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) … Continued